Phosphodiesterase-4 Activity A Critical Modulator of Atrial Contractility and Arrhythmogenesis

Departments of Molecular Cardiology and Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.
Journal of the American College of Cardiology (Impact Factor: 16.5). 06/2012; 59(24):2191-2. DOI: 10.1016/j.jacc.2012.03.027
Source: PubMed
Download full-text


Available from: David R. Van Wagoner, Jan 22, 2014
8 Reads
  • Source
    Journal of the American College of Cardiology 01/2013; 61(3):357-385. DOI:10.1016/j.jacc.2012.12.002 · 16.50 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: -Atrial fibrillation (AF) risk has been associated with "leaky" ryanodine receptor (RyR2) Ca release channels. Patients with mutations in RyR2 or in the sarcoplasmic reticulum Ca binding protein calsequestrin (Casq2) display an increased risk for AF. Here we examine the underlying mechanisms of AF associated with loss of Casq2 and test mechanism-based drug therapy. -Compared to wild-type mice, atrial burst pacing consistently induced atrial flutter or AF in Casq2(-/-) mice and in isolated Casq2(-/-) hearts. Atrial optical voltage maps obtained from isolated hearts revealed multiple independent activation sites arising predominantly from the pulmonary vein (PV) region. Ca and voltage mapping demonstrated sub-threshold diastolic Ca elevations (SCaE) and delayed afterdepolarizations (DADs) whenever the pacing train failed to induce AF. The dual RyR2 and Na channel inhibitor R-propafenone (3μM) significantly reduced frequency and amplitude of SCaE and DADs in atrial myocytes and intact atria and prevented induction of AF. In contrast, the S-enantiomer of propafenone, an equipotent Na channel blocker but much weaker RyR2 inhibitor, did not reduce SCaE and DADs and failed to prevent AF. -Loss of Casq2 increases risk of AF by promoting regional SCaE and DADs in atrial tissue, which can be prevented by RyR2 inhibition with R-propafenone. Targeting AF due to "leaky" RyR2 Ca channels with R-propafenone may be a more mechanism-based approach to treating this common arrhythmia.
    Circulation Arrhythmia and Electrophysiology 02/2014; 7(2). DOI:10.1161/CIRCEP.113.000994 · 4.51 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Cyclic nucleotides (cAMP & cGMP) are critical intracellular second messengers involved in the transduction of a diverse array of stimuli and their catabolism is mediated by phosphodiesterases (PDEs). We previously detected focal genomic amplification of PDE1C in >90 glioblastoma multiforme (GBM) cells suggesting a potential as a novel therapeutic target in these cells. In this report, we show that genomic gain of PDE1C was associated with increased expression in low passage GBM-derived cell cultures. We demonstrate that PDE1C is essential in driving cell proliferation, migration and invasion in GBM cultures since silencing of this gene significantly mitigates these functions. We also define the mechanistic basis of this functional effect through whole genome expression analysis by identifying down-stream gene effectors of PDE1C which are involved in cell cycle and cell adhesion regulation. In addition, we also demonstrate that Vinpocetine, a general PDE1 inhibitor, can also attenuate proliferation with no effect on invasion/migration. Up-regulation of at least one of this gene set (IL8, CXCL2, FOSB, NFE2L3, SUB1, SORBS2, WNT5A, and MMP1) in TCGA GBM cohorts is associated with worse outcome and PDE1C silencing down-regulated their expression, thus also indicating potential to influence patient survival. Therefore we conclude that proliferation, migration, and invasion of GBM cells could also be regulated downstream of PDE1C. © 2015 Wiley Periodicals, Inc.
    Molecular Carcinogenesis 01/2015; DOI:10.1002/mc.22276 · 4.81 Impact Factor